Disclosure Of Intangible Assets [Text Block]

Zealand Pharma - Filing #1440145

Concept 2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2018-01-01 to
2018-12-31
Disclosure of intangible assets [text block]
Research and development expense
604,081,000 DKK
561,423,000 DKK
438,219,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.